Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-17

FDA Approved: GYNAZOLE 1 — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for GYNAZOLE 1 (butoconazole nitrate) from Padagis Israel Pharmaceuticals Ltd, for the treatment of vaginal candidia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GYNAZOLE 1 (BUTOCONAZOLE NITRATE)

Snippet

SUPPL AP for GYNAZOLE 1 (BUTOCONAZOLE NITRATE)